geralt / Pixabay The News: Instead of less than 10% of drugs reaching the market, a new study has found that almost 15% of new compounds pass clinical trial–which still suggests that i… Read More

Charlottesville TomorrowGordon Laurie (L) and Mark Logan co-founded TearSolutions in 2013. The company’s drug candidate emerged from Laurie’s research at the University of Virgin… Read More

SEOUL, South Korea and SAN DIEGO, Feb. 05, 2018 (GLOBE NEWSWIRE) — Effective February 5th, 2018, Yuhan Corporation (KRX:000100.KS) (Yuhan) and Sorrento Therapeutics, Inc. (Nasdaq:SRNE)… Read More